Literature DB >> 571548

Cellular immune response against acetylcholine receptor in myasthenia gravis: I. Relevance to clinical course and pathogenesis.

B M Conti-Tronconi, M Morgutti, A Sghirlanzoni, F Clementi.   

Abstract

The cellular immune response to acetylcholine receptor from Torpedo electric organ was studied in 100 myasthenic patients and 41 healthy subjects. The mean stimulation index (SI) was 2 +/- 0.15 for the patients, and 1.06 +/- 0.08 for the controls. Stimulation was significantly greater when the test medium contained autologous serum rather than a standard universal serum (AB serum). Young patients were generally good responders (SI, 2.39 +/- 0.26), but older patients usually did not respond (mean SI, 1.18 +/- 0.13). Among the younger patients, men had higher responses than women (mean SI, 3.13 +/- 0.63 and 2.05 +/- 0.23, respectively). There was no correlation between degree of lymphocytic reactivity and duration or severity of symptoms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571548     DOI: 10.1212/wnl.29.4.496

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Phenotypic and functional characterization of T cells from patients with myasthenia gravis.

Authors:  F Mokhtarian; M Pino; W Ofosu-Appiah; D Grob
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Authors:  A Melms; B C Schalke; T Kirchner; H K Müller-Hermelink; E Albert; H Wekerle
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis.

Authors:  R Mantegazza; D Pareyson; F Baggi; P Romagnoli; D Peluchetti; A Sghirlanzoni; F Cornelio
Journal:  Ital J Neurol Sci       Date:  1988-04

5.  Specific involvement of peripheral T lymphocytes against acetylcholine receptors in myasthenia gravis.

Authors:  B M Conti-Tronconi; A Scotti; A Sghirlanzoni; F Clementi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-09       Impact factor: 10.154

6.  Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

Authors:  H J Sagar; G A Davies-Jones; I D Allonby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

Review 7.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

8.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.

Authors:  C M Gomez; R L Wollmann; D P Richman
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Cellular and humoral immunity to acetylcholine receptor in myasthenia gravis.

Authors:  B M Conti Tronconi; A Scotti; A Brigonzi; E Sher; G Fumagalli; D Peluchetti; F Clementi
Journal:  Ital J Neurol Sci       Date:  1982-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.